相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Collin M. Blakely et al.
NATURE GENETICS (2017)
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression
A. J. van der Wekken et al.
PLOS ONE (2017)
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata et al.
NATURE MEDICINE (2016)
The WNT-less wonder: WNT-independent β-catenin signaling
Zackie Aktary et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Notch-Induced Expression of FZD7 Requires Noncanonical NOTCH3 Signaling in Human Breast Epithelial Cells
Vasudeva Bhat et al.
STEM CELLS AND DEVELOPMENT (2016)
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Michael Ramirez et al.
NATURE COMMUNICATIONS (2016)
Mechanisms of resistance to EGFR-targeted drugs: lung cancer
Floriana Morgillo et al.
ESMO OPEN (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors As Adjuvant Therapy in Completely Resected Non-Small-Cell Lung Cancer
Silvia Novello
JOURNAL OF CLINICAL ONCOLOGY (2015)
Inhibition of beta-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non-small-cell Lung Cancer with a T790M Mutation
Yosuke Togashi et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
Chee-Seng Tan et al.
LANCET ONCOLOGY (2015)
RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth
Philippe Depeille et al.
NATURE CELL BIOLOGY (2015)
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
Anil Belur Nagaraj et al.
ONCOTARGET (2015)
EGFR Blockade Enriches for Lung Cancer Stem-like Cells through Notch3-Dependent Signaling
Rajeswara Rao Arasada et al.
CANCER RESEARCH (2014)
β-Catenin Contributes to Lung Tumor Development Induced by EGFR Mutations
Sohei Nakayama et al.
CANCER RESEARCH (2014)
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Heinz-Josef Lenz et al.
CANCER SCIENCE (2014)
SAMD9L Inactivation Promotes Cell Proliferation via Facilitating GI-S Transition in Hepatitis B Virus-associated Hepatocellular Carcinoma
Qun Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Regulated Proteolysis of NOTCH2 and NOTCH3 Receptors by ADAM10 and Presenilins
Arjan J. Groot et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells
Zuowei Zhao et al.
BREAST CANCER RESEARCH (2014)
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas
Alexis B. Cortot et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Impact of Mesenchymal Stem Cell secreted PAI-1 on colon cancer cell migration and proliferation
Niamh M. Hogan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
Yanyan Zheng et al.
CANCER CELL (2013)
Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer
Kyle David Proffitt et al.
CANCER RESEARCH (2013)
Genotyping and Genomic Profiling of Non-Small-Cell Lung Cancer: Implications for Current and Future Therapies
Tianhong Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
Matthew J. Niederst et al.
SCIENCE SIGNALING (2013)
Tankyrase and the Canonical Wnt Pathway Protect Lung Cancer Cells from EGFR Inhibition
Matias Casas-Selves et al.
CANCER RESEARCH (2012)
HB-EGF Is Necessary and Sufficient for Muller Glia Dedifferentiation and Retina Regeneration
Jin Wan et al.
DEVELOPMENTAL CELL (2012)
Histone H1 Recruitment by CHD8 Is Essential for Suppression of the Wnt-beta-Catenin Signaling Pathway
Masaaki Nishiyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Non-canonical Notch signaling: emerging role and mechanism
Peter Andersen et al.
TRENDS IN CELL BIOLOGY (2012)
Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians
Yongsheng Wang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Wnt/β-catenin Signaling in Normal and Cancer Stem Cells
Kenneth C. Valkenburg et al.
Cancers (2011)
Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
James P. Sullivan et al.
CANCER RESEARCH (2010)
Plasminogen Activator Inhibitor-1 Is a Transcriptional Target of the Canonical Pathway of Wnt/β-Catenin Signaling
Weichun He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non-Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study
Glenwood D. Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Raphael Kopan et al.
CELL (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
A regulatory pathway involving Notch1/β-catenin/Isl1 determines cardiac progenitor cell fate
Chulan Kwon et al.
NATURE CELL BIOLOGY (2009)
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023
Karen Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gadd45a regulates β-catenin distribution and maintains cell-cell adhesion/contact
J. Ji et al.
ONCOGENE (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?
H. Uramoto et al.
BRITISH JOURNAL OF CANCER (2007)
Transcriptional cooperation between the transforming growth factor-beta and wnt pathways in mammary and intestinal tumorigenesis
Etienne Labbe et al.
CANCER RESEARCH (2007)
Cancer and blood coagulation
C Boccaccio et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Notch3 and pre-TCR interaction unveils distinct NF-κB pathways in T-cell development and leukemia
A Vacca et al.
EMBO JOURNAL (2006)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
KH Emami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells
Q Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
